CrossRef Cited-by Linking Search Results

This Article:

has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking:

  • The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients
    Viktor Hlaváč, Veronika Brynychová, Radka Václavíková, Marie Ehrlichová, David Vrána, Václav Pecha, Markéta Trnková, Roman Kodet, Marcela Mrhalová, Kateřina Kubáčková, Jiří Gatěk, Petr Vážan, and Pavel Souček
    Medicine (2014) 93 :e255
  • Differential dependency network analysis to identify condition-specific topological changes in biological networks
    Bai Zhang, Huai Li, Rebecca B. Riggins, Ming Zhan, Jianhua Xuan, Zhen Zhang, Eric P. Hoffman, Robert Clarke, and Yue Wang
    Bioinformatics (2009) 25 :526
  • A Study on Genetic Variants of Fibroblast Growth Factor Receptor 2 (FGFR2) and the Risk of Breast Cancer from North India
    Sarah Siddiqui, Shilpi Chattopadhyay, Md. Salman Akhtar, Mohammad Zeeshan Najm, S. V. S. Deo, N. K. Shukla, Syed Akhtar Husain, and Nancy Lan Guo
    PLoS ONE (2014) 9 :e110426
  • Cellular Mechanisms of Zinc Dysregulation: A Perspective on Zinc Homeostasis as an Etiological Factor in the Development and Progression of Breast Cancer
    Samina Alam and Shannon L. Kelleher
    Nutrients (2012) 4 :875
  • A Novel Color Change Mechanism for Breast Cancer Biomarker Detection: Naphthoquinones as Specific Ligands of Human Arylamine N-Acetyltransferase 1
    Nicola Laurieri, James E. Egleton, Amy Varney, Cyrille C. Thinnes, Camilo E. Quevedo, Peter T. Seden, Sam Thompson, Fernando Rodrigues-Lima, Julien Dairou, Jean-Marie Dupret, Angela J. Russell, Edith Sim, and Syed A. Aziz
    PLoS ONE (2013) 8 :e70600
  • How different are luminal A and basal breast cancers?
    François Bertucci, Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe-Jauffret, Max Buttarelli, Jocelyne Jacquemier, Max Chaffanet, Dominique Maraninchi, Patrice Viens, and Daniel Birnbaum
    International Journal of Cancer (2009) 124 :1338
  • Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: Experience of the REMAGUS 02 phase II trial
    F. Valet, P. de Cremoux, F. Spyratos, N. Servant, M.E. Dujaric, D. Gentien, J. Lehmann-Che, V. Scott, B. Sigal-Zafrani, M.C. Mathieu, P. Bertheau, J.M. Guinebretière, J.Y. Pierga, S. Delaloge, S. Giacchetti, E. Brain, O. Tembo, M. Marty, and B. Asselain
    The Breast (2013) 22 :1052
  • miR-1290 and its potential targets are associated with characteristics of estrogen receptor  -positive breast cancer
    Y. Endo, T. Toyama, S. Takahashi, N. Yoshimoto, M. Iwasa, T. Asano, Y. Fujii, and H. Yamashita
    Endocrine Related Cancer (2013) 20 :91
  • RET in breast cancer: functional and therapeutic implications
    Andrea Morandi, Ivan Plaza-Menacho, and Clare M. Isacke
    Trends in Molecular Medicine (2011) 17 :149
  • A mechanism for epithelial–mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3)
    Christer Hogstrand, Peter Kille, Margaret Leigh Ackland, Stephen Hiscox, and Kathryn M. Taylor
    Biochemical Journal (2013) 455 :229
  • Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes
    Gabriela C. Fernandes, Rodrigo A. D. Michelli, Cristovam Scapulatempo-Neto, and Edenir I. Palmero
    Hereditary Cancer in Clinical Practice (2016) 14 :
  • Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family
    Sandeep Sanga, Bradley M Broom, Vittorio Cristini, and Mary E Edgerton
    BMC Medical Genomics (2009) 2 :
  • Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer
    Robert Clarke, Ayesha N. Shajahan, Yue Wang, John J. Tyson, Rebecca B. Riggins, Louis M. Weiner, William T. Bauman, Jianhua Xuan, Bai Zhang, Caroline Facey, Harini Aiyer, Katherine Cook, F. Edward Hickman, Iman Tavassoly, Anael Verdugo, Chun Chen, Alan Zwart, Anni Wärri, and Leena A. Hilakivi-Clarke
    Hormone Molecular Biology and Clinical Investigation (2011) 5 :
  • Comparative evaluation of ERα and ERβ significance in breast cancer: state of the art
    Etienne Leygue and Leigh Murphy
    Expert Review of Endocrinology & Metabolism (2011) 6 :333
  • Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer
    Oncology Reports (2012) 27 :1277
  • FGFR2 Abnormalities Underlie a Spectrum of Bone, Skin, and Cancer Pathologies
    Masaru Katoh
    Journal of Investigative Dermatology (2009) 129 :1861
  • Methylated polycyclic aromatic hydrocarbons and/or their metabolites are important contributors to the overall estrogenic activity of polycyclic aromatic hydrocarbon-contaminated soils
    Monika M. Lam, Magnus Engwall, Michael S. Denison, and Maria Larsson
    Environmental Toxicology and Chemistry (2018) 37 :385
  • Genetic Ablation of Caveolin-1 Drives Estrogen-Hypersensitivity and the Development of DCIS-Like Mammary Lesions
    Isabelle Mercier, Mathew C. Casimiro, Jie Zhou, Chenguang Wang, Christopher Plymire, Kelly G. Bryant, Kristin M. Daumer, Federica Sotgia, Gloria Bonuccelli, Agnieszka K. Witkiewicz, Justin Lin, Thai Hong Tran, Janet Milliman, Philippe G. Frank, Jean-François Jasmin, Hallgeir Rui, Richard G. Pestell, and Michael P. Lisanti
    The American Journal of Pathology (2009) 174 :1172
  • Identification of Gene Expression Signature in Estrogen Receptor Positive Breast Carcinoma
    Arvind D. Thakkar, Hemanth Raj, Debarshi Chakrabarti, Ravishankar, N. Saravanan, Bhaskaran Muthuvelan, Arun Balakrishnan, and Muralidhara Padigaru
    Biomarkers in Cancer (2010) 2 :BIC.S3793
  • HER4 Intracellular Domain (4ICD) Activity in the Developing Mammary Gland and Breast Cancer
    Frank E. Jones
    Journal of Mammary Gland Biology and Neoplasia (2008) 13 :247
  • A seven-gene prognostic model for platinum-treated ovarian carcinomas
    R Sabatier, P Finetti, J Bonensea, J Jacquemier, J Adelaide, E Lambaudie, P Viens, D Birnbaum, and F Bertucci
    British Journal of Cancer (2011) 105 :304
  • Zinc transporter mRNA expression in the RWPE-1 human prostate epithelial cell line
    Amy L. Albrecht, Seema Somji, Mary Ann Sens, Donald A. Sens, and Scott H. Garrett
    BioMetals (2008) 21 :405
  • The Role of Hepsin in Endometrial Carcinoma
    Hala S. El-Rebey, Mona A.-H. Kandil, Rehab M. Samaka, Dalia R. Al-Sharaky, and Karim El Deeb
    Applied Immunohistochemistry & Molecular Morphology (2017) 25 :624
  • Targeting RET for thyroid cancer therapy
    Cinzia Lanzi, Giuliana Cassinelli, Valentina Nicolini, and Franco Zunino
    Biochemical Pharmacology (2009) 77 :297
  • Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4
    J. I. Partanen, T. A. Tervonen, and J. Klefstrom
    Philosophical Transactions of the Royal Society B: Biological Sciences (2013) 368 :20130111
  • Estrogen-Mediated Upregulation of Noxa Is Associated with Cell Cycle Progression in Estrogen Receptor-Positive Breast Cancer Cells
    Wensheng Liu, Wendy M. Swetzig, Rajesh Medisetty, Gokul M. Das, and Deodutta Roy
    PLoS ONE (2011) 6 :e29466
  • Fibroblast growth factor receptors, developmental corruption and malignant disease
    F. C. Kelleher, H. O'Sullivan, E. Smyth, R. McDermott, and A. Viterbo
    Carcinogenesis (2013) 34 :2198
  • ER and PR signaling nodes during mammary gland development
    Tamara Tanos, Lucia Jimenez Rojo, Pablo Echeverria, and Cathrin Brisken
    Breast Cancer Research (2012) 14 :
  • Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes
    Dadi Jiang, Brandon Turner, Jie Song, Ruijiang Li, Maximilian Diehn, Quynh-Thu Le, Purvesh Khatri, and Albert C. Koong
    JCO Precision Oncology (2017) :1
  • Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells
    Raymond Lo, Lyle Burgoon, Laura MacPherson, Shaimaa Ahmed, and Jason Matthews
    Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2010) 1799 :469
  • Estrogen regulation of X-box binding protein-1 and its role in estrogen induced growth of breast and endometrial cancer cells
    Surojeet Sengupta, Catherine G.N. Sharma, and V. Craig Jordan
    Hormone Molecular Biology and Clinical Investigation (2010) 2 :
  • TaqI polymorphism of VDR gene contributes to breast cancer risk
    Hua Wang, Wenjian Wang, Dongjie Yang, and Shenming Wang
    Tumor Biology (2014) 35 :93
  • Systemic identification of estrogen-regulated genes in breast cancer cells through cap analysis of gene expression mapping
    Ryonosuke Yamaga, Kazuhiro Ikeda, Joost Boele, Kuniko Horie-Inoue, Ken-ichi Takayama, Tomohiko Urano, Kaoru Kaida, Piero Carninci, Jun Kawai, Yoshihide Hayashizaki, Yasuyoshi Ouchi, Michiel de Hoon, and Satoshi Inoue
    Biochemical and Biophysical Research Communications (2014) 447 :531
  • Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
    Ida Johansson, Cecilia Nilsson, Pontus Berglund, Martin Lauss, Markus Ringnér, Håkan Olsson, Lena Luts, Edith Sim, Sten Thorstensson, Marie-Louise Fjällskog, and Ingrid Hedenfalk
    Breast Cancer Research (2012) 14 :
  • Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
    Mikko Pelkonen, Kaisa Luostari, Maria Tengström, Hermanni Ahonen, Bozena Berdel, Vesa Kataja, Ylermi Soini, Veli-Matti Kosma, and Arto Mannermaa
    BMC Cancer (2015) 15 :
  • Significant gene expression differences in histologically “Normal” liver biopsies: Implications for control tissue
    Tarik Asselah, Ivan Bièche, Ingrid Laurendeau, Michelle Martinot-Peignoux, Valerie Paradis, Dominique Vidaud, Dominique-Charles Valla, Pierre Bedossa, Patrick Marcellin, and Michel Vidaud
    Hepatology (2008) 48 :953
  • Structure–activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1
    James E. Egleton, Cyrille C. Thinnes, Peter T. Seden, Nicola Laurieri, Siu Po Lee, Kate S. Hadavizadeh, Angelina R. Measures, Alan M. Jones, Sam Thompson, Amy Varney, Graham M. Wynne, Ali Ryan, Edith Sim, and Angela J. Russell
    Bioorganic & Medicinal Chemistry (2014) 22 :3030
  • Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting
    Anieta M. Sieuwerts, Maria B. Lyng, Marion E. Meijer-van Gelder, Vanja de Weerd, Fred C.G.J. Sweep, John A. Foekens, Paul N. Span, John W.M. Martens, and Henrik J. Ditzel
    Molecular Oncology (2014) 8 :1679
  • Estrogen signaling and unfolded protein response in breast cancer
    Gayani Rajapaksa, Christoforos Thomas, and Jan-Åke Gustafsson
    The Journal of Steroid Biochemistry and Molecular Biology (2016) 163 :45
  • Investigation of G-quadruplex formation in the FGFR2 promoter region and its transcriptional regulation by liensinine
    Lulu Zhang, Wei Tan, Jiang Zhou, Ming Xu, and Gu Yuan
    Biochimica et Biophysica Acta (BBA) - General Subjects (2017) 1861 :884
  • Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk
    Hong Wang, Ziang Yang, and Hongwei Zhang
    Breast Cancer Research and Treatment (2013) 137 :511
  • ArylamineN-acetyltransferase 1 expression in breast cancer cell lines: A potential marker in estrogen receptor-positive tumors
    Larissa Wakefield, James Robinson, Hilary Long, J. Claire Ibbitt, Susanna Cooke, Helen C. Hurst, and Edith Sim
    Genes, Chromosomes and Cancer (2008) 47 :118
  • Are trefoil factors oncogenic?
    Jo K. Perry, Nagarajan Kannan, Prudence M. Grandison, Murray D. Mitchell, and Peter E. Lobie
    Trends in Endocrinology & Metabolism (2008) 19 :74
  • Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer
    Zachary E. Stine, David M. McGaughey, Seneca L. Bessling, Shengchao Li, and Andrew S. McCallion
    Human Molecular Genetics (2011) 20 :3746
  • Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells
    Albana Gattelli, Ivan Nalvarte, Anne Boulay, Tim C. Roloff, Martin Schreiber, Neil Carragher, Kenneth K. Macleod, Michaela Schlederer, Susanne Lienhard, Lukas Kenner, Maria I. Torres-Arzayus, and Nancy E. Hynes
    EMBO Molecular Medicine (2013) 5 :1335
  • NF-κB Signaling Is Required for XBP1 (Unspliced and Spliced)-Mediated Effects on Antiestrogen Responsiveness and Cell Fate Decisions in Breast Cancer
    Rong Hu, Anni Warri, Lu Jin, Alan Zwart, Rebecca B. Riggins, Hong-Bin Fang, and Robert Clarke
    Molecular and Cellular Biology (2015) 35 :379
  • A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays
    Sanjib Chaudhary, B. Madhu Krishna, and Sandip K. Mishra
    Oncology Letters (2017) 14 :1247
  • Novel genes associated with lymph node metastasis in triple negative breast cancer
    Andrea Mathe, Michelle Wong-Brown, Brianna Morten, John F. Forbes, Stephen G. Braye, Kelly A. Avery-Kiejda, and Rodney J. Scott
    Scientific Reports (2015) 5 :
  • Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferases
    P. J. Ballester, I. Westwood, N. Laurieri, E. Sim, and W. G. Richards
    Journal of The Royal Society Interface (2010) 7 :335
  • A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
    Angelika Brekman, Kathryn E Singh, Alla Polotskaia, Nandini Kundu, and Jill Bargonetti
    Breast Cancer Research (2011) 13 :
  • A candidate molecular signature associated with tamoxifen failure in primary breast cancer
    Julie A Vendrell, Katherine E Robertson, Patrice Ravel, Susan E Bray, Agathe Bajard, Colin A Purdie, Catherine Nguyen, Sirwan M Hadad, Ivan Bieche, Sylvie Chabaud, Thomas Bachelot, Alastair M Thompson, and Pascale A Cohen
    Breast Cancer Research (2008) 10 :
  • Recent Advances in the Role of SLC39A/ZIP Zinc Transporters In Vivo
    Teruhisa Takagishi, Takafumi Hara, and Toshiyuki Fukada
    International Journal of Molecular Sciences (2017) 18 :2708
  • Small Molecule Colorimetric Probes for Specific Detection of Human ArylamineN-Acetyltransferase 1, a Potential Breast Cancer Biomarker
    Nicola Laurieri, Matthew H. J. Crawford, Akane Kawamura, Isaac M. Westwood, James Robinson, Ai M. Fletcher, Stephen G. Davies, Edith Sim, and Angela J. Russell
    Journal of the American Chemical Society (2010) 132 :3238
  • Hydroxysteroid Sulfotransferase SULT2B1b Promotes Hepatocellular Carcinoma Cells Proliferation In Vitro and In Vivo
    Xiaoming Yang, Yali Xu, Fenghua Guo, Yanxia Ning, Xiuling Zhi, Lianhua Yin, Xiaobo Li, and Jun Sun
    PLoS ONE (2013) 8 :e60853
  • Cooperating transcription factors mediate the function of estrogen receptor
    Elisa Fiorito, Madhumohan R. Katika, and Antoni Hurtado
    Chromosoma (2013) 122 :1
  • Enigma Prevents Cbl-c-Mediated Ubiquitination and Degradation of RETMEN2A
    Stephen C. Kales, Marion M. Nau, Anand S. Merchant, Stanley Lipkowitz, and Adriano Marchese
    PLoS ONE (2014) 9 :e87116
  • Neurotrophins and their receptors in breast cancer
    Hubert Hondermarck
    Cytokine & Growth Factor Reviews (2012) 23 :357
  • Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers
    Alison K. Ward, Paul Mellor, Shari E. Smith, Stephanie Kendall, Natasha A. Just, Frederick S. Vizeacoumar, Sabuj Sarker, Zoe Phillips, Riaz Alvi, Anurag Saxena, Franco J. Vizeacoumar, Svein A. Carlsen, and Deborah H. Anderson
    Breast Cancer Research (2016) 18 :
  • Expression of the RET Proto-oncogene Is Regulated by TFAP2C in Breast Cancer Independent of the Estrogen Receptor
    Philip M. Spanheimer, George W. Woodfield, Anthony R. Cyr, Mikhail V. Kulak, Lola S. White-Baer, Thomas B. Bair, and Ronald J. Weigel
    Annals of Surgical Oncology (2013) 20 :2204
  • Fibroblasts maintained in 3 dimensions show a better differentiation state and higher sensitivity to estrogens
    Claudia Montani, Nathalie Steimberg, Jennifer Boniotti, Giorgio Biasiotto, Isabella Zanella, Giuseppe Diafera, Ida Biunno, Luigi Caimi, Giovanna Mazzoleni, and Diego Di Lorenzo
    Toxicology and Applied Pharmacology (2014) 280 :421
  • Zinc as a Gatekeeper of Immune Function
    Nutrients (2017) 9 :1286
  • Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole
    William R Miller and Alexey Larionov
    Breast Cancer Research (2010) 12 :
  • Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression
    Joel Smith, Martin L. Read, Jon Hoffman, Rachel Brown, Beth Bradshaw, Christopher Campbell, Trevor Cole, Johanna Dieguez Navas, Fiona Eatock, Justin S. Gundara, Eric Lian, Dom Mcmullan, Neil V. Morgan, Lois Mulligan, Patrick J. Morrison, Mercedes Robledo, Michael A. Simpson, Vicki E. Smith, Sue Stewart, Richard C. Trembath, Stan Sidhu, Fiona S. Togneri, Naomi C. Wake, Yvonne Wallis, John C. Watkinson, Eamonn R. Maher, Christopher J. McCabe, and Emma R. Woodward
    Human Molecular Genetics (2016) 25 :1836
  • Interrogating differences in expression of targeted gene sets to predict breast cancer outcome
    Sarah A Andres, Guy N Brock, and James L Wittliff
    BMC Cancer (2013) 13 :
  • Cancer outlier detection based on likelihood ratio test
    Jianhua Hu
    Bioinformatics (2008) 24 :2193
  • Recent advances on the stimulatory effects of metals in breast cancer
    Rosamaria Lappano, Roberta Malaguarnera, Antonino Belfiore, and Marcello Maggiolini
    Molecular and Cellular Endocrinology (2017) 457 :49
  • The Physiological, Biochemical, and Molecular Roles of Zinc Transporters in Zinc Homeostasis and Metabolism
    Taiho Kambe, Tokuji Tsuji, Ayako Hashimoto, and Naoya Itsumura
    Physiological Reviews (2015) 95 :749
  • Dysregulated RET Signaling in Thyroid Cancer
    Maria Domenica Castellone and Massimo Santoro
    Endocrinology and Metabolism Clinics of North America (2008) 37 :363
  • Polychlorinated biphenyls and breast cancer: A congener-specific meta-analysis
    Ling Leng, Jing Li, Xiu-mei Luo, Jun-young Kim, Yi-meng Li, Xue-mei Guo, Xi Chen, Qiao-yun Yang, Guang Li, and Nai-jun Tang
    Environment International (2016) 88 :133
  • A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes
    B Dutta, L Pusztai, Y Qi, F André, V Lazar, G Bianchini, N Ueno, R Agarwal, B Wang, C Y Shiang, G N Hortobagyi, G B Mills, W F Symmans, and G Balázsi
    British Journal of Cancer (2012) 106 :1107
  • CYP2B6*6 is associated with increased breast cancer risk
    Christina Justenhoven, Daniela Pentimalli, Sylvia Rabstein, Volker Harth, Anne Lotz, Beate Pesch, Thomas Brüning, Thilo Dörk, Peter Schürmann, Natalia Bogdanova, Tjoung-Won Park-Simon, Fergus J. Couch, Janet E. Olson, Peter A. Fasching, Matthias W. Beckmann, Lothar Häberle, Arif Ekici, Per Hall, Kamilla Czene, Janjun Liu, Jingmei Li, Christian Baisch, Ute Hamann, Yon-Dschun Ko, and Hiltrud Brauch
    International Journal of Cancer (2014) 134 :426
  • Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples
    Timothy R. Wilson, Yuanyuan Xiao, Jill M. Spoerke, Jane Fridlyand, Hartmut Koeppen, Eloisa Fuentes, Ling Y. Huw, Ilma Abbas, Arjan Gower, Erica B. Schleifman, Rupal Desai, Ling Fu, Teiko Sumiyoshi, Joyce A. O’Shaughnessy, Garret M. Hampton, and Mark R. Lackner
    Breast Cancer Research and Treatment (2014) 148 :315
  • Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer
    Neill Patani, Wen G Jiang, and Kefah Mokbel
    Cancer Cell International (2011) 11 :23
  • Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives
    Amir Tajbakhsh, Amin Mokhtari-Zaer, Mehdi Rezaee, Fahimeh Afzaljavan, Mehdi Rivandi, Seyed Mahdi Hassanian, Gordon A Ferns, Alireza Pasdar, and Amir Avan
    Journal of Cellular Biochemistry (2017) 118 :2502
  • Investigation of Antitumor Effects of Sorafenib and Lapatinib Alone and in Combination on MCF-7 Breast Cancer Cells
    Turgut Kacan, Ahmet Altun, Gulsah Gultekin Altun, Selen Baloglu Kacan, Bulent Sarac, Mehmet Metin Seker, Aykut Bahceci, and Nalan Babacan
    Asian Pacific Journal of Cancer Prevention (2014) 15 :3185
  • Estrogen Alters the Splicing of Type 1 Corticotropin-Releasing Hormone Receptor in Breast Cancer Cells
    S. Lal, A. Allan, D. Markovic, R. Walker, J. Macartney, N. Europe-Finner, A. Tyson-Capper, and D. K. Grammatopoulos
    Science Signaling (2013) 6 :ra53
  • Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2
    Angela J. Russell, Isaac M. Westwood, Matthew H.J. Crawford, James Robinson, Akane Kawamura, Christina Redfield, Nicola Laurieri, Edward D. Lowe, Stephen G. Davies, and Edith Sim
    Bioorganic & Medicinal Chemistry (2009) 17 :905
  • Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation
    C. Hogstrand, P. Kille, R.I. Nicholson, and K.M. Taylor
    Trends in Molecular Medicine (2009) 15 :101
  • Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance
    Rodney F. Minchin and Neville J. Butcher
    BMC Genomics (2018) 19 :
  • Crosstalk Between theFGFR2andTP53Genes in Breast Cancer: Data from an Association Study and Epistatic Interaction Analysis
    Nadezhda V. Cherdyntseva, Evgeny V. Denisov, Nicolay V. Litviakov, Vladimir N. Maksimov, Elena A. Malinovskaya, Natalia N. Babyshkina, Elena M. Slonimskaya, Mikhail I. Voevoda, and Evgeny L. Choinzonov
    DNA and Cell Biology (2012) 31 :306
  • Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer
    Marie-Emmanuelle Legrier, Ivan Bièche, Julie Gaston, Arnaud Beurdeley, Vanessa Yvonnet, Olivier Déas, Aurélie Thuleau, Sophie Château-Joubert, Jean-Luc Servely, Sophie Vacher, Myriam Lassalle, Stéphane Depil, Gordon C Tucker, Jean-Jacques Fontaine, Marie-France Poupon, Sergio Roman-Roman, Jean-Gabriel Judde, Didier Decaudin, Stefano Cairo, and Elisabetta Marangoni
    British Journal of Cancer (2016) 114 :177
  • Chromatin context dominates estrogen regulation of pS2 gene expression
    Akua K. Oduro, Michael K. Fritsch, and Fern E. Murdoch
    Experimental Cell Research (2008) 314 :2796
  • Mammalian Zinc Transporters: Nutritional and Physiologic Regulation
    Louis A. Lichten and Robert J. Cousins
    Annual Review of Nutrition (2009) 29 :153
  • Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells
    Robert Clarke, Ayesha N. Shajahan, Rebecca B. Riggins, Younsook Cho, Anatasha Crawford, Jianhua Xuan, Yue Wang, Alan Zwart, Ruchi Nehra, and Minetta C. Liu
    The Journal of Steroid Biochemistry and Molecular Biology (2009) 114 :8
  • Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10
    Petra EA Huijts, Minka van Dongen, Moniek CM de Goeij, Adrian J van Moolenbroek, Freek Blanken, Maaike PG Vreeswijk, Esther M de Kruijf, Wilma E Mesker, Erik W van Zwet, Rob AEM Tollenaar, Vincent THBM Smit, Christi J van Asperen, and Peter Devilee
    Breast Cancer Research (2011) 13 :
  • Overexpression of SULT2B1b is an independent prognostic indicator and promotes cell growth and invasion in colorectal carcinoma
    Liang Hu, Guang-Zhen Yang, Yu Zhang, Dan Feng, Yan-Xia Zhai, Hui Gong, Chen-Ye Qi, Hao Fu, Ming-Ming Ye, Qing-Ping Cai, and Chun-Fang Gao
    Laboratory Investigation (2015) 95 :1005
  • Determining and Interpreting New Predictive Rules for Breast Cancer Familial Inheritance
    Stefania Tommasi, Giuseppina Iannelli, Filippo Menolascina, Vita Fedele, Vitoantonio Bevilacqua, and Angelo Paradiso
    OMICS: A Journal of Integrative Biology (2011) 15 :125
  • Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells
    Tan-chi Fan, Hui Ling Yeo, Huan-Ming Hsu, Jyh-Cherng Yu, Ming-Yi Ho, Wen-Der Lin, Nai-Chuan Chang, John Yu, and Alice L. Yu
    Cancer Letters (2018) 434 :184
  • Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer
    Jessica M Grunda, Adam D Steg, Qinghua He, Mark R Steciuk, Suzanne Byan-Parker, Martin R Johnson, and William E Grizzle
    BMC Research Notes (2012) 5 :248
  • Zinc and its transporter ZIP6 are key mediators of breast cancer cell survival under high glucose conditions
    Chihiro Matsui, Tomoka Takatani-Nakase, Yuki Hatano, Satomi Kawahara, Ikuhiko Nakase, and Koichi Takahashi
    FEBS Letters (2017) 591 :3348
  • Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women
    J. Liang, P. Chen, Z. Hu, X. Zhou, L. Chen, M. Li, Y. Wang, J. Tang, H. Wang, and H. Shen
    Carcinogenesis (2008) 29 :2341
  • Protein tyrosine phosphatases as novel targets in breast cancer therapy
    Caroline E. Nunes-Xavier, Jorge Martín-Pérez, Ari Elson, and Rafael Pulido
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2013) 1836 :211
  • Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents
    Jonathan McConathy, Weiping Yu, Nachwa Jarkas, Wonewoo Seo, David M. Schuster, and Mark M. Goodman
    Medicinal Research Reviews (2012) 32 :868
  • New Potential Biomarker Proteins for Alcoholic Liver Disease Identified by a Comparative Proteomics Approach
    Su Jin Lee, Da Eun Lee, Jeong Han Kang, Min-Jeong Nam, Jeen-Woo Park, Beom Sik Kang, Dong-Seok Lee, Hyun-Shik Lee, and Oh-Shin Kwon
    Journal of Cellular Biochemistry (2017) 118 :1189
  • Activation function 2 mediates dioxin-induced recruitment of estrogen receptor alpha to CYP1A1 and CYP1B1
    Laura MacPherson, Raymond Lo, Shaimaa Ahmed, Andrea Pansoy, and Jason Matthews
    Biochemical and Biophysical Research Communications (2009) 385 :263
  • Epidermal Growth Factor Receptor (EGFR)-mediated Positive Feedback of Protein-tyrosine Phosphatase ϵ (PTPϵ) on ERK1/2 and AKT Protein Pathways Is Required for Survival of Human Breast Cancer Cells
    Caroline E. Nunes-Xavier, Ari Elson, and Rafael Pulido
    Journal of Biological Chemistry (2012) 287 :3433
  • Distinct Pathways Regulated by RET and Estrogen Receptor in Luminal Breast Cancer Demonstrate the Biological Basis for Combination Therapy
    Philip M. Spanheimer, Anthony R. Cyr, Matthew P. Gillum, George W. Woodfield, Ryan W. Askeland, and Ronald J. Weigel
    Annals of Surgery (2014) 259 :793
  • A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow
    Kjersti Tjensvoll, Bjørnar Gilje, Satu Oltedal, Victor F. Shammas, Jan Terje Kvaløy, Reino Heikkilä, and Oddmund Nordgård
    Breast Cancer Research and Treatment (2009) 116 :329
  • RET: A Multi-Faceted Gene in Human Cancer
    Massimo Santoro, Francesca Carlomagno, and Rosa Marina Melillo
    Endocrinology and Metabolism (2012) 27 :173